Inhibition of replication in functional mouse adrenal tumor cells by adrenocorticotropic hormone mediated by adenosine 3':5'-cyclic monophosphate.
Adrenocorticotropic hormone (ACTH) inhibited replication in functional adrenal tumor cells with a concomitant stimulation of steroidogenesis and a characteristic change of morphology from a flattened to a spherical type. [(3)H]Thymidine incorporation into DNA was inhibited by about 50% 6 hours after ACTH treatment. Both cyclic AMP and dibutyryl cyclic AMP inhibited [(3)H]thymidine incorporation and caused the characteristic morphological change noted with ACTH. The extent of stimulation of steroidogenesis and the amount of inhibition of [(3)H]thymidine incorporation in response to various doses of ACTH were closely related and both were in parallel with the concentration of cyclic AMP in the cells. Cyclic GMP and cyclic IMP did not inhibit [(3)H]thymidine incorporation significantly, and did not change the morphology of the cells. AMP inhibited [(3)H]thymidine incorporation into DNA and caused the characteristic morphological change. However, AMP did not increase the cyclic AMP content of the cells. CMP, GMP, and UMP showed a significant inhibition of [(3)H]thymidine incorporation into DNA, but the extent of the inhibition was much less than that with AMP. These nucleotides did not change the morphology of the cells.
D000310:Adrenal Gland Neoplasms / Q000378:metabolism*; D000311:Adrenal Glands / Q000187:drug effects; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology*; D000616:Aminoglutethimide / Q000494:pharmacology; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003348:Cortisone / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D006152:Cyclic GMP / Q000494:pharmacology; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003864:Depression, Chemical; D006854:Hydrocortisone / Q000494:pharmacology; D066298:In Vitro Techniques; D007292:Inosine Nucleotides / Q000494:pharmacology; D007930:Leucine; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis*; D009374:Neoplasms, Experimental / Q000378:metabolism*; D011241:Prednisone / Q000494:pharmacology; D012334:RNA, Neoplasm / Q000096:biosynthesis; D013256:Steroids / Q000096:biosynthesis; D013936:Thymidine; D014316:Tritium; D014529:Uridine
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D007292:Inosine Nucleotides; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D013256:Steroids; D000616:Aminoglutethimide; D014316:Tritium; D000324:Adrenocorticotropic Hormone; D000242:Cyclic AMP; D007930:Leucine; D006152:Cyclic GMP; D003348:Cortisone; D011241:Prednisone; D013936:Thymidine; D014529:Uridine; D006854:Hydrocortisone